UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Strategic performance measurement in a healthcare organisation: A multiple criteria approach based on balanced scorecard

Omega (Oxford), 2012, Vol.40 (1), p.104-119

2012

Volltextzugriff (PDF)

P505 Smoking is associated with the development of adverse events of biological therapy in patients with Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i466-i466

2022

Volltextzugriff (PDF)

P768 The prevalence and risk factors for malignancies in patients with inflammatory bowel disease in Crete : a case control study

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i896-i899

2023

Volltextzugriff (PDF)

P231 Impact of age of Inflammatory Bowel Disease diagnosis on disease phenotype and severity in elderly patients

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i385-i385

2023

Volltextzugriff (PDF)

P411 Faecal calprotectin is more tightly associated with endoscopic disease activity compared with other biomarkers in patients with inflammatory bowel disease under maintenance treatment with adalimumab

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S377-S377

2020

Volltextzugriff (PDF)

P478 The role of proactive measurement of adalimumab trough levels and antibodies to adalimumab in Greek patients with Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i447-i448

2022

Volltextzugriff (PDF)

P570 Prevalence and risk factors for intestinal resection in patients with Crohn’s disease in a Greek referral center

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i511-i512

2022

Volltextzugriff (PDF)

P453 The use of immunosuppresants is associated with high treatment persistence rates for infliximab and adalimumab as first or second line anti-TNF therapy in patients with inflammatory bowel disease

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S447-S448

2021

Volltextzugriff (PDF)

P408 Long-term impact of the decrease of infliximab trough levels on the disease course in Inflammatory Bowel Disease patients under maintenance treatment with infliximab

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S375-S376

2020

Volltextzugriff (PDF)

P339 Effect of antinuclear antibodies on pharmacokinetics of anti-TNF therapy in patients with Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i354-i355

2022

Volltextzugriff (PDF)

PO4-8GENERAL KNOWLEDGE ON ALCOHOL AND ALCOHOL USE IN A COHORT OF CRETAN LIVER DISEASE PATIENTS

Alcohol and alcoholism (Oxford), 2017-10, Vol.52 (suppl_1), p.i31-i49

2017

Volltextzugriff (PDF)

P639 Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?

Journal of Crohn's and colitis, 2019-01, Vol.13 (Supplement_1), p.S438-S438

2019

Volltextzugriff (PDF)

P348 Persistent hyperCKemia during infliximab therapy in patients with inflammatory bowel disease

Journal of Crohn's and colitis, 2017-02, Vol.11 (suppl_1), p.S254-S254

2017

Volltextzugriff (PDF)

P796 Cardiovascular risk profile in Greek patients with inflammatory bowel disease

Journal of Crohn's and colitis, 2019-01, Vol.13 (Supplement_1), p.S520-S520

2019

Volltextzugriff (PDF)

P668 Real world use and adverse events of SARs-CoV-2 vaccination in Greek patients with Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i576-i577

2022

Volltextzugriff (PDF)

PO4-11A NATURAL HISTORY STUDY OF DECOMPENSATED ALCOHOLIC CIRRHOSIS IN CRETE. RECENT IMPROVEMENT IN SURVIVAL

Alcohol and alcoholism (Oxford), 2017-10, Vol.52 (suppl_1), p.i31-i49

2017

Volltextzugriff (PDF)

P447 Infliximab trough levels are decreasing overtime in patients with inflammatory bowel disease on maintenance treatment with infliximab

Journal of Crohn's and colitis, 2018-01, Vol.12 (supplement_1), p.S330-S331

2018

Volltextzugriff (PDF)

P406 Observational study of the effectiveness of vedolizumab on treatment outcomes and health-related quality of life in biologic-naïve patients with Inflammatory Bowel Diseases in Greece – the TROVE study - Interim Analysis

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i535-i536

2023

Volltextzugriff (PDF)

P677 Patients with Inflammatory Bowel Diseases on anti-TNF treatment have impaired antibody production after Anti-SARS-CoV-2 vaccination: Results from a Panhellenic registry

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i581-i582

2022

Volltextzugriff (PDF)

P641 Implementation and short-term adverse events of anti-SARS-CoV-2 vaccines in Inflammatory Bowel Disease patients: an international web-based survey

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i558-i558

2022

Volltextzugriff (PDF)

Peripheral primitive neuroectodermal tumour during pregnancy

British journal of radiology, 2002-06, Vol.75 (894), p.543-547

2002

Volltextzugriff (PDF)

Effects of Doxycycline, Metronidazole and their Combination on Candida species Colonization of the Human Oropharynx, Intestinal Lumen and Vagina

Journal of chemotherapy (Florence), 2003-08, Vol.15 (4), p.369-373

2003

Volltextzugriff (PDF)

Effects of doxycycline, metronidazole and their combination on Candida species colonization of the human oropharynx, intestinal lumen and vagina

Journal of chemotherapy (Florence), 2003, Vol.15 (3), p.369-373

2003

Volltextzugriff (PDF)

Keeping on the High Quality of Health Care in Greek Inflammatory Bowel Disease Patients in the SARS-CoV-2 Era

Clinical gastroenterology and hepatology, 2020-09, Vol.18 (10), p.2380-2381

2020

Volltextzugriff (PDF)

Effect of antinuclear antibodies on pharmacokinetics of anti-TNF therapy in patients with inflammatory bowel disease

International journal of colorectal disease, 2022-03, Vol.37 (3), p.639-646

2022

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(53)
Berichte
(2)

Sprache

Englisch
(55)

Erscheinungsjahr

n.n

Thema

Science & Technology
(24)
Life Sciences & Biomedicine
(22)
Gastroenterology & Hepatology
(14)
Humans
(11)
Infliximab
(8)
Ulcerative Colitis
(7)
Female
(6)
Inflammatory Bowel Disease
(6)
Inflammatory Bowel Diseases
(5)
Inflammatory Bowel Diseases - Drug Therapy
(4)
Middle Aged
(4)
Surgery
(4)
Adult
(3)
Aga Abstracts
(3)
Crohn's Disease
(3)
Crohn’s Disease
(3)
Poster Presentations
(3)
Prospective Studies
(3)
Retrospective Studies
(3)
Tumor Necrosis Factor Inhibitors
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Strategic performance measurement in a healthcare organisation: A multiple criteria approach based on balanced scorecard

P505 Smoking is associated with the development of adverse events of biological therapy in patients with Inflammatory Bowel Disease

P768 The prevalence and risk factors for malignancies in patients with inflammatory bowel disease in Crete : a case control study

P231 Impact of age of Inflammatory Bowel Disease diagnosis on disease phenotype and severity in elderly patients

P411 Faecal calprotectin is more tightly associated with endoscopic disease activity compared with other biomarkers in patients with inflammatory bowel disease under maintenance treatment with adalimumab

P478 The role of proactive measurement of adalimumab trough levels and antibodies to adalimumab in Greek patients with Inflammatory Bowel Disease

P570 Prevalence and risk factors for intestinal resection in patients with Crohn’s disease in a Greek referral center

P453 The use of immunosuppresants is associated with high treatment persistence rates for infliximab and adalimumab as first or second line anti-TNF therapy in patients with inflammatory bowel disease

P408 Long-term impact of the decrease of infliximab trough levels on the disease course in Inflammatory Bowel Disease patients under maintenance treatment with infliximab

P339 Effect of antinuclear antibodies on pharmacokinetics of anti-TNF therapy in patients with Inflammatory Bowel Disease

PO4-8GENERAL KNOWLEDGE ON ALCOHOL AND ALCOHOL USE IN A COHORT OF CRETAN LIVER DISEASE PATIENTS

P639 Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?

P348 Persistent hyperCKemia during infliximab therapy in patients with inflammatory bowel disease

P796 Cardiovascular risk profile in Greek patients with inflammatory bowel disease

P668 Real world use and adverse events of SARs-CoV-2 vaccination in Greek patients with Inflammatory Bowel Disease

PO4-11A NATURAL HISTORY STUDY OF DECOMPENSATED ALCOHOLIC CIRRHOSIS IN CRETE. RECENT IMPROVEMENT IN SURVIVAL

P447 Infliximab trough levels are decreasing overtime in patients with inflammatory bowel disease on maintenance treatment with infliximab

P406 Observational study of the effectiveness of vedolizumab on treatment outcomes and health-related quality of life in biologic-naïve patients with Inflammatory Bowel Diseases in Greece – the TROVE study - Interim Analysis

P677 Patients with Inflammatory Bowel Diseases on anti-TNF treatment have impaired antibody production after Anti-SARS-CoV-2 vaccination: Results from a Panhellenic registry

P641 Implementation and short-term adverse events of anti-SARS-CoV-2 vaccines in Inflammatory Bowel Disease patients: an international web-based survey

Peripheral primitive neuroectodermal tumour during pregnancy

Effects of Doxycycline, Metronidazole and their Combination on Candida species Colonization of the Human Oropharynx, Intestinal Lumen and Vagina

Effects of doxycycline, metronidazole and their combination on Candida species colonization of the human oropharynx, intestinal lumen and vagina

Keeping on the High Quality of Health Care in Greek Inflammatory Bowel Disease Patients in the SARS-CoV-2 Era

Effect of antinuclear antibodies on pharmacokinetics of anti-TNF therapy in patients with inflammatory bowel disease

Suchergebnisse filtern